News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Articles|March 1, 2003

Coughing up a throat culture

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

Immune endotype linked to poorer recovery in pediatric sepsis, organ failure | Image Credit: © Zerbor - stock.adobe.com

Immune endotype linked to poorer recovery in pediatric sepsis, organ failure

ByMorgan Ebert, Executive Editor

June 12th 2026

Handheld optical device detects necrotizing enterocolitis in premature infants before radiographic signs appear | Image Credit: © Rattanachat - stock.adobe.com

Handheld optical device detects necrotizing enterocolitis in premature infants before radiographic signs appear

ByMorgan Ebert, Executive Editor

June 11th 2026

Megan Cole Brahim, PhD, on addressing mental health concerns during pediatric primary care visits

Megan Cole Brahim, PhD, on addressing mental health concerns during pediatric primary care visits

ByMegan Cole Brahim, PhD, MPH

June 11th 2026

ADA 2026 data highlight pediatric outcomes and treatment satisfaction with Afrezza

ADA 2026 data highlight pediatric outcomes and treatment satisfaction with Afrezza

ByKevin Kunzmann,Morgan Ebert, Executive Editor

June 11th 2026

FDA expands TOFIDENCE (tocilizumab-bavi) indications to include CAR T-cell–induced CRS and pediatric COVID-19

FDA expands TOFIDENCE (tocilizumab-bavi) indications to include CAR T-cell–induced CRS and pediatric COVID-19

ByMorgan Ebert, Executive Editor

June 10th 2026

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

ADA 2026 data highlight pediatric outcomes and treatment satisfaction with Afrezza

New sunscreen ingredient clears FDA for the first time since the 1990s

FDA grants GEn-1123 rare disease designations for Duchenne muscular dystrophy

FDA accepts vedolizumab sBLA for pediatric ulcerative colitis and Crohn's disease

FDA approves lebrikizumab every-8-week maintenance dosing for moderate-to-severe atopic dermatitis